47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,7 | 2,7 | -0,1 | -102,4 |
EBITDA | -0,4 | 2,9 | 0,2 | -94 |
Short time liabilities | 1 | 2,1 | 2,4 | 13,1 |
Equity capital | -2,5 | 0,1 | 0,1 | -47,6 |
Operating profit (EBIT) | -0,4 | 2,9 | 0,2 | -94 |
Assets | 1,8 | 4,7 | 5,1 | 8,9 |
Net profit (loss) | -0,7 | 2,7 | -0,1 | -102,4 |
Cash | 0,2 | 0,6 | 0,4 | -33 |
Net income from sale | 10,9 | 17,9 | 25,5 | 42,7 |
Liabilities and provisions for liabilities | 4,4 | 4,5 | 5 | 10,6 |
Working assets | 1,8 | 4,4 | 4,9 | 11,6 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 27,2 | 1974,2 | -90,8 | -2065 |
Equity capital to total assets | -137,7 | 2,9 | 1,4 | -1,5 |
Gross profit margin | -6,3 | 15 | -0,3 | -15,3 |
EBITDA Margin | -3,4 | 16,5 | 0,7 | -15,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 32 | 44 | 35 | -9 |
Current financial liquidity indicator | 1.8610790967941284 | 2.0530223846435547 | 2.0242252349853516 | -0,1 |
Net dept to EBITDA | -8.706192970275879 | 0.6479419469833374 | 12.841511726379395 | 12,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane